Teva intros generic Axiron in the U.S.

JERUSALEM — Teva late last week announced the launch of generic Axiron (testosterone) topical solution CIII, 30-mg-1.5-mL, in the United States.

Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testosterone due to certain medical conditions. It is supplied in a metered dose pump with an underarm applicator.

Axiron had annual sales of approximately $247 million in the U.S., according to IMS data as of May 2017.